Cindy Joanne Mazur, MBA

Cindy Joanne Mazur, MBA, Six Sigma Certified, is an accomplished clinical scientist with over 15 years of experience in clinical research and operations. She has contributed to the advancement of patient care through pioneering work in oncology, rare diseases, CNS disorders, and dermatology. Currently, she serves as Associate Director of Clinical Sciences, focusing on study startup, Phase 1 trials, and operational efficiencies in drug development. Her career has spanned top biotechnology and pharmaceutical organizations, as well as early-stage startups, allowing her to combine scientific insight with strategic leadership.

Mazur’s expertise lies in implementing novel therapeutic technologies, including bispecific antibodies, cell and gene therapy, and CRISPR-based innovations. She has been instrumental in establishing trial master files, developing Phase 1 clinical units, and ensuring compliance across complex research protocols. Her work bridges the gap between clinical science and operational execution, always with a patient-centered perspective that emphasizes safety, precision, and innovative solutions.

Beyond her professional achievements, Mazur is committed to mentorship, philanthropy, and community engagement. She actively supports charitable organizations for children and the homeless and participates in professional societies such as Toastmasters International and the International Women’s Club. Her dedication to clinical research, coupled with her compassionate approach, has established her as a trusted leader and advocate for patients participating in clinical trials.

• Felician University – Triple Major in Mathematics, Science, and Nursing (Minor)
• Seton Hall University – MBA Certification, Minor in Pharmaceutical Management
• Villanova School of Business – Six Sigma Project Management Efficiencies Certification
• Rutgers School of Nursing – Clinical Research Professionalization Certification

• MBA
• Six Sigma Project Management Efficiencies
• Clinical Research Professionalization

• AARP
• Board of Directors, Felician University
• International Women’s Club Member
• Toastmasters International – VP of PR

• Charities for children
• Charities for the homeless
• Mendham Women’s Club Philanthropy

Joint publication on Myeloproliferative Neoplasms (MPN/MF) presented at a Society of Oncology conference in Vienna, 2022

Speaking engagements on pharmaceutical study startup and clinical trial efficiencies